(DCGO) DocGo - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US2560861096
DCGO: Ambulance, Wheelchair, Transportation, Medical, Health, Emergency
DocGo Inc. (NASDAQ:DCGO) operates as a provider of mobile health and medical transportation services, primarily serving healthcare providers in the United States and the United Kingdom. The company offers a range of services, including emergency response and non-emergency transportation, such as ambulance and wheelchair transport. Additionally, DocGo provides mobile health services delivered at various locations, including homes, offices, and event venues, such as sporting events and concerts. The company also offers total care management solutions, which include healthcare services and ancillary support like shelter arrangements. Headquartered in New York, DocGo was established in 2015 and has expanded its operations to address diverse healthcare needs. For more information, visit their website at https://www.docgo.com.
Based on the provided data, here is a three-month forecast for DocGo Inc. (NASDAQ:DCGO):
Technical Outlook: The stock is currently trading below its 20-day and 50-day moving averages, which may indicate near-term weakness. However, the 200-day moving average suggests longer-term support. Average daily volume of 754,583 shares indicates moderate liquidity, which could lead to volatility. The ATR of 0.24 reflects relatively stable price movements.
Fundamental Outlook: With a market cap of $486.31 million, DocGo is positioned as a mid-sized player in the healthcare equipment sector. The P/E ratio of 16.52 suggests the market expects growth, while the forward P/E of 250.00 indicates high future earnings expectations. The P/B ratio of 1.57 points to moderate valuation relative to book value. The P/S ratio of 0.70 indicates reasonable valuation relative to sales. The return on equity (RoE) of 9.48% reflects moderate profitability.
Forecast: Over the next three months, DocGo Inc. is likely to experience sideways to slightly upward movement, with potential resistance near the 20-day moving average of $4.97. Support is expected near the 200-day moving average of $3.73. Fundamental strength, driven by growth in mobile health services and event-based healthcare, could offset technical headwinds. Investors should monitor volume trends and earnings updates for clearer direction.
Additional Sources for DCGO Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
DCGO Stock Overview
Market Cap in USD | 309m |
Sector | Healthcare |
Industry | Medical Care Facilities |
GiC Sub-Industry | Health Care Equipment |
IPO / Inception | 2021-11-05 |
DCGO Stock Ratings
Growth 5y | -56.3% |
Fundamental | 13.7% |
Dividend | 0.0% |
Rel. Strength Industry | -17.8 |
Analysts | 4.86/5 |
Fair Price Momentum | 2.17 USD |
Fair Price DCF | 14.61 USD |
DCGO Dividends
No Dividends PaidDCGO Growth Ratios
Growth Correlation 3m | -11.8% |
Growth Correlation 12m | 46% |
Growth Correlation 5y | -82.1% |
CAGR 5y | -26.05% |
CAGR/Max DD 5y | -0.35 |
Sharpe Ratio 12m | -0.06 |
Alpha | -25.90 |
Beta | 0.91 |
Volatility | 104.41% |
Current Volume | 1059.3k |
Average Volume 20d | 1057.8k |
As of March 14, 2025, the stock is trading at USD 2.87 with a total of 1,059,309 shares traded.
Over the past week, the price has changed by -2.05%, over one month by -48.38%, over three months by -33.10% and over the past year by -18.00%.
Neither. Based on ValueRay Fundamental Analyses, DocGo is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 13.68 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DCGO as of March 2025 is 2.17. This means that DCGO is currently overvalued and has a potential downside of -24.39%.
DocGo has received a consensus analysts rating of 4.86. Therefor, it is recommend to buy DCGO.
- Strong Buy: 6
- Buy: 1
- Hold: 0
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, DCGO DocGo will be worth about 2.4 in March 2026. The stock is currently trading at 2.87. This means that the stock has a potential downside of -16.03%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 5.1 | 76% |
Analysts Target Price | 6.2 | 116.7% |
ValueRay Target Price | 2.4 | -16% |